Company Data
Pharvaris N.V.
Ticker
PHVS
Current Price
$28.04 -4.51%
Market Cap
$1.5B
Price Target
Refer to Report
Volume
249.1K
52wk Range
$11.51 - $29.665
Overview
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications.